Atypical Spitz tumours across age groups: clinicopathological features, management strategies and long-term outcomes in a 20-year retrospective cohort study
Open Access
- 1 September 2026
- journal article
- Published by Oxford University Press (OUP) in Skin Health and Disease
Abstract
Background: Atypical Spitz tumours (ASTs) sit between Spitz naevi and spitzoid melanoma; age may modulate morphology and outcome. Objectives: To compare recurrence-free survival (RFS) across prespecified age groups and test associations with histological aggressiveness and sentinel lymph node biopsy (SLNB) status. Methods: A retrospective cohort study of patients with ASTs was carried out at two Italian tertiary centres (1 January 2002–31 December 2022). Patients were grouped according to age: ≤18, 19–25, 26–39 and ≥40 years. The primary endpoint was RFS from definitive excision. The secondary endpoints were Breslow thickness, mitotic rate and SLNB positivity. Kaplan–Meier and nonparametric tests were carried out; data were missing in <5% of cases. Results: A total of 187 patients (57 male and 130 female individuals; mean age 37 years) were included. Mean Breslow thickness (2.33 mm in patients aged ≤18 years vs. 0.88 mm in patients aged ≥ 40 years; P < 0.001) and mean mitotic activity (1.89 mitoses mm–2 in patients aged ≤18 years vs. 0.15 mitoses mm–2 in patients aged ≥ 40 years; P < 0.001) decreased with age. Of 148 patients who underwent re-excision, 44 (29.7%) underwent SLNB; 12 of 44 (27%) were positive (42% in children; 9% in adults). Median follow-up was 40 months (interquartile range 18–79); one local recurrence occurred in a 47-year-old patient, later reclassified as conventional melanoma. There were no distant metastases or melanoma-related deaths. Five-year RFS was 100% for patients aged ≤ 39 years and 98% for those aged ≥ 40 years (log-rank P = 0.30). SLNB positivity did not predict recurrence (0/12 positive vs. 1/32 negative). Conclusions: Across this 20-year, dual-centre series, ASTs had excellent outcomes at all ages. Paediatric ASTs were thicker and more mitotically active yet clinically indolent. These findings support conservative excision without routine SLNB in children and a selective, multidisciplinary approach in adults.Keywords
Funding Information
- Ministero della Salute
This publication has 26 references indexed in Scilit:
- Empirical investigations into Kruskal-Wallis power studies utilizing Bernstein fits, simulations and medical study datasetsScientific Reports, 2023
- An update on genomic aberrations in Spitz naevi and tumoursPathology, 2022
- Incidence and outcome of Spitzoid tumour of unknown malignant potential (STUMP): an analysis of cases in the Netherlands from 1999 to 2014British Journal of Dermatology, 2020
- Atypical ALK‐positive Spitz tumors with 9p21 homozygous deletion: Report of two cases and review of the literatureJournal of Cutaneous Pathology, 2017
- TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic NeoplasmsScientific Reports, 2015
- Atypical Spitz tumours and sentinel lymph node biopsy: a systematic reviewThe Lancet Oncology, 2014
- Stratified Fisher's exact test and its sample size calculationBiometrical Journal, 2013
- The surgical management of Spitz naevi and atypical spitzoid neoplasms: A review of the literatureThe Surgeon, 2013
- Spitz nevi and other Spitzoid lesionsJournal of the American Academy of Dermatology, 2011
- Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysisLaboratory Investigation, 2005